Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.52 USD | -5.09% | -0.46% | -4.54% |
Mar. 08 | Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing | MT |
Mar. 08 | AxoGen, Inc. Announces Executive Changes | CI |
Business Summary
Number of employees: 427
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peripheral Nerve Regeneration and Repair
100.0
%
| 139 | 100.0 % | 159 | 100.0 % | +14.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 139 | 100.0 % | 159 | 100.0 % | +14.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Karen Zaderej
CEO | Chief Executive Officer | 62 | 06-04-30 |
Nir Naor
DFI | Director of Finance/CFO | 50 | Dec. 05 |
Marc Began
CMP | Compliance Officer | 57 | 23-03-05 |
Ivica Ducic
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-04 |
Gregory Freitag
BRD | Director/Board Member | 62 | 10-05-31 |
Todd Puckett
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | 21-12-31 | |
Jens Kemp
SAM | Sales & Marketing | - | 23-02-12 |
Erick DeVinney
PRN | Corporate Officer/Principal | 48 | 07-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Thomas
BRD | Director/Board Member | 68 | 20-09-29 |
Director/Board Member | 63 | 16-08-31 | |
John Johnson
BRD | Director/Board Member | 66 | 21-07-18 |
Guido Neels
BRD | Director/Board Member | 75 | 15-08-25 |
Karen Zaderej
CEO | Chief Executive Officer | 62 | 06-04-30 |
Gregory Freitag
BRD | Director/Board Member | 62 | 10-05-31 |
Alan Levine
BRD | Director/Board Member | 63 | 19-05-14 |
William Burke
BRD | Director/Board Member | 55 | 22-07-10 |
Joseph Tyndall
BRD | Director/Board Member | 55 | 22-12-12 |
Kathy Weiler
BRD | Director/Board Member | 55 | Dec. 19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,704,574 | 40,214,067 ( 92.01 %) | 0 | 92.01 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.54% | 285M | |
+7.71% | 218B | |
+6.25% | 182B | |
+10.60% | 132B | |
+26.73% | 108B | |
-0.30% | 62.51B | |
+15.42% | 52.98B | |
-1.89% | 47.59B | |
-1.91% | 39.96B | |
+11.16% | 39.22B |
- Stock Market
- Equities
- AXGN Stock
- Company AxoGen, Inc.